¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"population diffusion coefficient"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion tensor imaging
    È®»êÅÙ¼­¿µ»ó
  • diffusion time
    È®»ê½Ã°£
  • diffusion weighted imaging
    È®»ê°­Á¶¿µ»ó
  • diffusion-limited transport
    È®»êÁ¦ÇÑ¿î¹Ý
  • facilitated diffusion
    ÃËÁøÈ®»ê, Áß°³È®»ê
  • gel diffusion precipitin reaction
    °ÖÈ®»êħÀü¹ÝÀÀ
  • island population
    °í¸³Àα¸Áý´Ü
  • identity diffusion
    Á¤Ã¼¼ºÈ®»ê
  • infinite population
    ¹«ÇѸðÁý´Ü
  • model population
    ¸ðÇüÀα¸
  • natural population
    ÀÚ¿¬Áý´Ü
  • population
    1. Àα¸ 2. ¸ðÁý´Ü, Áý´Ü
  • population attributable risk
    ¸ðÁý´Ü±âÀÎÀ§Çèµµ
  • population density
    Àα¸¹Ðµµ
  • population dynamics
    Àα¸µ¿ÅÂ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population variance
    ¸ðÁý´ÜºÐ»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population
    Àα¸, ¸ðÁý´Ü
  • population policy
    Àα¸Á¤Ã¥
  • population pyramid
    Àα¸¸ðÇü, Àα¸ÇǶó¹Ìµå
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼
  • population variance
    ¸ðÁý´ÜºÐ»ê
  • population attributable risk
    ÀϹÝÀα¸±â¿©À§Çèµµ
  • population excess rate
    ¸ðÁý´ÜÃʰúÀ²
  • population mortality table
    ±¹¹Î»ç¸Á·üÇ¥
  • reference population
    ±âÁØÁý´Ü
  • stable population
    ¾ÈÁ¤Àα¸
  • standard population
    Ç¥ÁØÀα¸
  • stationary population
    Á¤ÁöÀα¸
  • target population
    Ç¥ÀûÁý´Ü
  • virgin population
    ¹«³ëÃâÀα¸
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Ficks law of diffusion
    ÇÈÀÇ È®»ê(üªß¤)¹ýÄ¢(ÛööÎ)
  • Oudins agar diffusion
    ¿ìµ­ ÇÑõȮ»ê¹ý
  • agar diffusion
    ÇÑõ(³»)È®»ê(¡­üªß¤).
  • agar diffusion method
    ÇÑõ(³»)È®»ê¹ý.
  • agar gel diffusion
    ÇÑõ°ÖÈ®»ê(ùÎô¸¡­üªß¤).
  • anisotropic diffusion
    ºñµî¹æ¼º È®»ê
  • antigen diffusion constant
    Ç׿øÈ®»ê»ó¼ö(ù÷ê«üªß¤ßÈâ¦).
  • free diffusion
    ÀÚÀ¯È®»ê.
  • gas diffusion
    °¡½ºÈ®»ê, °¡½º¹Ì»ê
  • gel diffusion
    ÇÑõȮ»ê
  • gel diffusion precipitin reaction
    ÇÑõȮ»ê ħ°­¹ÝÀÀ
  • gel diffusion test, quantitative
    ÇÑõȮ»ê Á¤·®¹ý
  • heavily diffusion weighted MRI
    Áß È®»ê °­Á¶ ÀÚ±â°ø¸í¿µ»ó
  • identity diffusion
    Á¤Ã¼¼º È®»ê
  • population
    Àα¸, ¸ðÁý´Ü(ËÎ̤ËÀ) Åë°èÀÇ , Áý´Ü, °³Ã¼±º(˧̧˴).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population equivalent
    Àα¸´ç·®(ÊÙËÀËâ).
  • population genetics
    Áý´ÜÀ¯ÀüÇÐ(ÊÙËôËøÌ°).
  • population growth
    Àα¸¼ºÀå(ËöË´ËÛËö).
  • population increase
    Àα¸Áõ°¡(ÊÙ̡˧).
  • population mean
    ¸ðÆò±Õ(ËḬ̂˻).
  • population mortality table
    ±¹¹Î»ý¸íÇ¥(Ë´ËÑË×ËḬ̂), ±¹¹Î»ç¸Á·üÇ¥(Ë´ËÑË×ËÎ Ëô̰).
  • population mutation
    Áý´Ü±ºµ¹¿¬º¯ÀÌ(¡­ÔÍæÔܨì¶).
  • population policy
    Àα¸Á¤Ã¥(ÊÙËøÌ¤).
  • population problem
    Àα¸¹®Á¦.
  • population pyramid
    Àα¸¸ðÇü(ËöË´ËÎÌ´).
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • population study
    Àα¸Á¶»ç
  • population trend
    Àα¸Ãß¼¼(ÊÙ̧ËÛ).
  • population variance
    ¸ðºÐ»ê(ËÎËÓË×).
  • stable population
    ¾ÈÁ¤Àα¸(ËâËøËöË´).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • eddy diffusion
    ¿ÍÈ®»ê(è¾üªß¤)
  • exchange diffusion
    ±³È¯ È®»ê (Îßüµüªß¤)
  • facilitated diffusion
    ÃËÁøÈ®»ê (õµòäüªß¤)
  • film diffusion
    Çʸ§ È®»ê(üªß¤)
  • forced diffusion
    °­Á¦ È®»ê(Ë­ð¤üªß¤)
  • free diffusion
    ÀÚÀ¯ È®»ê(í»ë¦üªß¤)
  • gel diffusion
    Á© È®»ê(üªß¤)
  • lateral diffusion
    Ãø¸éÈ®»ê(ö°Øüüªß¤)
  • particle diffusion
    ÀÔÀÚÈ®»ê(Ø£í­üªß¤)
  • passive diffusion
    ¼öµ¿ È®»ê(áôÔÑüªß¤)
  • restricted diffusion
    Á¦ÇÑ È®»ê(ð¤ùÚüªß¤)
  • restricted diffusion chromatography
    Á¦ÇÑ È®»ê Å©·Î¸¶Åä±×·¡ÇÇ
  • rotational diffusion
    ȸÀü È®»ê(üÞï®üªß¤)
  • simple diffusion
    ´Ü¼øÈ®»ê(Ó¤âíüªß¤)
  • single diffusion
    ´ÜÈ®»ê(Ó¤üªß¤)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • diffusion spectroscopy
    È®»êºÐ±¤¹ý
  • diffusion tensor imaging [=DTI]
    È®»êÅÙ¼­¿µ»ó
  • diffusion time
    È®»ê½Ã°£
  • diffusion weighted imaging [=DWI]
    È®»ê°­Á¶¿µ»ó
  • exchange diffusion
    ±³È¯È®»ê
  • heavily diffusion weighted MRI
    ÁßÈ®»ê°­Á¶ÀÚ±â°ø¸í¿µ»ó
  • perfusion and diffusion imaging
    °ü·ùÈ®»ê¿µ»ó
  • self diffusion
    ÀÚ°¡È®»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CPDL cumulative population doubling level
CPK cell population kinetic [model]; creatine phosphokinase
CPS carbamoylphosphate synthetase; cardioplegic perfusion solution; centipoise; cervical pain syndrome; ...
GCP geriatric cancer population; granulocyte chemotactic protein
HARP homeless and at-risk population
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EPESE Established Population for Epidemiologic Studies of the Elderly
NPHS National Population Health Survey
POHEM POpulation HEalth Model
PAR Population Attributable Risk
PD Population doublings
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • diffusion rate
    È®»êÀ²
  • double diffusion test
    ÀÌÁß È®»ê ½ÃÇè
  • exchange diffusion
    ±³È¯ È®»ê
  • facilitated diffusion
    ÃËÁø È®»ê, Áß°³ È®»ê
  • heavily diffusion weighted MRI
    ÁßÈ®»ê °­Á¶ Àڱ⠰ø¸í ¿µ»ó
  • law of diffusion
    È®»ê¹ýÄ¢
    ¸ðµç ¹°ÁúÀº °í³óµµ¿¡¼­ Àú³óµµ·Î ¹°ÁúÀÌ À̵¿ÇÑ´Ù.
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • perfusion and diffusion imaging
    °ü·ù È®»ê ¿µ»ó
  • simple diffusion
    ´Ü¼ø È®»ê, ´Ü¼ø È®»ê¹ý
  • thermal diffusion
    ¿­ È®»ê
    È¥ÇÕ À¯Ã¼ÀÇ ³»ºÎ¿¡ ¿Âµµ ±¸¹è°¡ ÀÖÀ» ¶§ ¼ººÐ¿¡ µû¶ó °¢°¢ °í¿Â Ãø°ú Àú¿Â ÃøÀ¸·Î ¸ð¿© ºÐ¸®µÇ´Â Çö»ó.
  • turbulent diffusion
    ¿Í·ù È®»ê
  • active coefficient
    Ȱ¼ºµµ °è¼ö
    ¹°ÁúÀÇ ³óµµ°¡ ³·À» ¶§¿¡ ¹ÝÀÀ·ÂÀº ³óµµ¿¡ ºñ·ÊÇϴµ¥ ³óµµ°¡ ³ô¾ÆÁ³À» ¶§´Â ¹ÝÀÀ·ÂÀÌ °¨¼ÒµÇ°í, ³óµµ¿¡ Ȱµ¿°è¼ö¸¦ °öÇÑ °Í¿¡ ºñ·ÊÇØ¼­ ¹ÝÀÀ·ÂÀÌ ³ªÅ¸³­´Ù.
  • attenuation coefficient
    °¨¼è °è¼ö
    ¾î¶² ƯÁ¤ÇÑ ¹°ÁúÀ» Åë°úÇÔÀ¸·Î½á ·¹ÀÌÀú ±¤¼ÓÀÇ Æò±ÕÃâ·ÂÀÇ »ó½Ç ȤÀº °¨¼ÒÀÇ ºñÀ².
  • capacity coefficient
    ¿ë·® °è¼ö
  • coefficient
    °è¼ö, À²
    1. ¾î¶² ÀÎÀÚÀÇ º¯µ¿À¸·Î ÃÊ·¡µÇ´Â º¯È­³ª È¿°úÀÇ Ç¥Çö. ¶Ç´Â µÎ °³ÀÇ ´Ù¸¥ ¾çÀÇ ¹èÀ²ÀÇ Ç¥Çö. 2. È­Çп¡¼­´Â È­ÇнÄÀÇ ¾Õ¿¡¼­ ±× È­ÇнÄÀÇ ¹èÀ²À» °¡¸®Å°´Â ¼ýÀÚ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
synchronous cell population <cell culture> A culture of cells that all divide in synchrony.
Particularly useful for certain studies of the cell cycle, cells can be made synchronous by depriving them of essential molecules, which are then restored. Synchronisation breaks down after a few cycles, however, as individual cells have unique division rates.
(19 Jan 1998)
q in population genetics The frequency of the less common of two different alternative (allelic) versions of a gene. (the frequency of the more common allele is p).
(12 Dec 1998)
topotypical population <zoology> Population occurring at the type locality from which the type specimen was taken.
(09 Jan 1998)
urban population The inhabitants of a city or town, including metropolitan areas and suburban areas.
(12 Dec 1998)
ambipolar diffusion <radiobiology> Diffusion process in which buildup of spatial charge creates electric fields which cause electrons and ions to leave the plasma at the same rate. (Such electric fields are self-generated by the plasma and act to preserve charge neutrality.)
(09 Oct 1997)
anomalous diffusion <radiobiology> Diffusion in most plasma devices, particularly tokamaks, is higher than what one would predict from understood causes. The observed, typical diffusion is referred to as anomalous because it has not yet been explained.
Anomalous diffusion includes all diffusion which is not due to collisions and geometric effects. While such effects were not understood when the term was coined, and most still are not, diffusion due to well-understood wave phenomena is still 'anomalous'. Classical diffusion and Neo-classical diffusion are the two well-understood diffusion theories, although neither is adequate to fully explain the observed anomalous diffusion.
See: entries for classical diffusion and neoclassical diffusion. Anomalous resistivity
(09 Oct 1997)
bohm diffusion <radiobiology> A rapid loss of plasma across magnetic field lines caused by microinstabilities. Theory formulated by the physicist David Bohm.
Semiempirical formula for the diffusion coefficient given by Bohm in 1946 (noted by Bohm, Burhop, and Massey, who were developing a magnetic arc for use in uranium isotope separation). Bohm diffusion was proposed (not derived from first principles) to scale as 1/B rather than the 1/B^2 scaling predicted by classical diffusion. A 1/B scaling results from assuming that particles diffuse across field lines at an optimum rate (effective collision frequency=cyclotron frequency). The 1/B scaling is observed (approximately) in most reactors.
See: diffusion, microinstabilities, field lines.
(09 Oct 1997)
gel diffusion Diffusion in a gel, as in the case of gel diffusion precipitin tests in which the immune reactants diffuse in agar.
See: immunodiffusion.
(05 Mar 2000)
gel diffusion precipitin tests Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
gel diffusion precipitin tests in one dimension Precipitin test's in which antigen solution and antibody incorporated in agar are layered in tubes, permitting effective diffusion in the vertical dimension; the antibody-containing agar may be overlaid directly with antigen solution (single (gel) diffusion in one dimension).
(05 Mar 2000)
gel diffusion precipitin tests in two dimensions Precipitin test's made in a layer of agar that permits radial diffusion, in both of the horizontal dimensions, of one or both reactants. Double (gel) diffusion in two dimensions (Ouchterlony test, technique, or method) incorporates antigen and antibody solutions placed in separate wells in a sheet of plain agar, permitting radial diffusion of both reactants; this method is widely used to determine antigenic relationships; the bands of precipitate that form where the reactants meet in optimal concentration are of three patterns, referred to as reaction of identity, reaction of partial identity (cross-reaction), and reaction of nonidentity.
(05 Mar 2000)
gel diffusion reactions Precipitin test's in which the immune precipitate forms in a gel medium (usually agar) into which one or both reactants have diffused; generally classified in two types, in one dimension, and in two dimensions.
Synonym: gel diffusion reactions.
(05 Mar 2000)
passive diffusion See: facilitated transport.
(05 Mar 2000)
classical diffusion <radiobiology> In plasma physics, diffusion due solely to scattering (collisions) of charged particles (with unlike charges) via electrical (Coulomb) interactions. (See also diffusion.)
(09 Oct 1997)
neoclassical diffusion <radiobiology> In a magnetised plasma, _classical_ diffusion refers to transport of particles due to Coulomb collisions, taking the spiral orbits in the magnetic field into account. In a toroidal magnetic field, the actual rate of diffusive transport is much higher due to slow changes in the positions of the centres of the spirals, known as banana orbits.
This faster transport is called _neo-classical_. With very few exceptions the transport in toroidal devices is observed to be 10-100 times larger still, presumably due to small-scale turbulence. The observed transport is called _anomalous_ (although it actually is the normal state).
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • population genetics
    Áý´Ü À¯ÀüÇÐ
  • population inversion
    ¹ÝÀü ºÐÆ÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á